Acquire the license to the best health content in the world
Contact Us

Clinical Trials Update: May 21, 2004

Lung Cancer Hepatitis Colorectal Cancer

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Lung Cancer

A research study to determine whether an investigational medication has an effect as a 2nd-line treatment in non-small cell lung cancer ("NSCLC") for patients having failed one prior platinum-containing chemotherapy regimen. Volunteers at least 18 who have had one previous treatment of a platinum-based drug such as cisplatin or carboplatin may be eligible. Research sites located throughout the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat34.html.

-----

Hepatitis

A research study of a combination of medications for patients with hepatitis C. Volunteers ages 18 - 65 who have not been treated with ribavirin/peg-interferon in past six months may be eligible. Research site located in Orlando, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat79.html.

-----

Colorectal Cancer

A research study of an investigational medication for the treatment of colorectal cancer. Volunteers 18 or older who have a history of colorectal cancer that has spread to other organs and have adequately recovered from recent surgery, chemotherapy or radiation therapy may be eligible. Research site located in Bronx, NY.

More information

Please see http://www.centerwatch.com/patient/studies/cat426.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News